{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T04:11:48Z","timestamp":1792642308006,"version":"4.5.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T00:00:00Z","timestamp":1727222400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T00:00:00Z","timestamp":1727222400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Oncol"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s10147-024-02628-7","type":"journal-article","created":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T03:33:48Z","timestamp":1727235228000},"page":"1967-1976","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Real-world application of comprehensive genomic profiling for gynecological malignancies: a multicenter observational study"],"prefix":"10.1007","volume":"29","author":[{"given":"Mayu","family":"Fukuda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1240-5422","authenticated-orcid":false,"given":"Koji","family":"Yamanoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobutaka","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Kotani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuki","family":"Yamano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisanori","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahito","family":"Ashihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaoru","family":"Abiko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukio","family":"Yamanishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoko","family":"Iemura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mana","family":"Taki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryusuke","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihito","family":"Horie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junzo","family":"Hamanishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Mandai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,25]]},"reference":[{"key":"2628_CR1","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.nbt.2012.05.004","volume":"29","author":"A Zieba","year":"2012","unstructured":"Zieba A, Grannas K, Soderberg O et al (2012) Molecular tools for companion diagnostics. N Biotechnol 29:634\u2013640","journal-title":"N Biotechnol"},{"key":"2628_CR2","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/j.annonc.2024.04.005","volume":"35","author":"MF Mosele","year":"2024","unstructured":"Mosele MF, Westphalen CB, Stenzinger A et al (2024) Recommendations for the use of next-generation sequencing (NGS) for patients with advanced cancer in 2024: a report from the ESMO Precision Medicine Working Group. Ann Oncol 35:588\u2013606","journal-title":"Ann Oncol"},{"key":"2628_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2023.101586","volume":"8","author":"HH Loong","year":"2023","unstructured":"Loong HH, Shimizu T, Prawira A et al (2023) Recommendations for the use of next-generation sequencing in patients with metastatic cancer in the Asia-Pacific region: a report from the APODDC working group. ESMO Open 8:101586","journal-title":"ESMO Open"},{"key":"2628_CR4","doi-asserted-by":"publisher","DOI":"10.1200\/PO.19.00291","author":"H Ebi","year":"2019","unstructured":"Ebi H, Bando H (2019) Precision oncology and the Universal Health Coverage System in Japan. JCO Precis Oncol. https:\/\/doi.org\/10.1200\/PO.19.00291","journal-title":"JCO Precis Oncol"},{"key":"2628_CR5","unstructured":"Ganjoho service. https:\/\/ganjoho.jp\/public\/qa_links\/report\/statistics\/2022_en.html Accessed Aug 2024"},{"key":"2628_CR6","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1158\/2159-8290.CD-22-0417","volume":"12","author":"T Kohno","year":"2022","unstructured":"Kohno T, Kato M, Kohsaka S et al (2022) C-CAT: the national datacenter for cancer genomic medicine in Japan. Cancer Discov 12:2509\u20132515","journal-title":"Cancer Discov"},{"key":"2628_CR7","doi-asserted-by":"publisher","first-page":"13","DOI":"10.2217\/pme.14.74","volume":"12","author":"S Garfeld","year":"2015","unstructured":"Garfeld S, Douglas MP, MacDonald KV et al (2015) Consumer familiarity, perspectives and expected value of personalized medicine with a focus on applications in oncology. Per Med 12:13\u201322","journal-title":"Per Med"},{"key":"2628_CR8","doi-asserted-by":"publisher","first-page":"2753","DOI":"10.1200\/JCO.2014.60.4165","volume":"33","author":"F Meric-Bernstam","year":"2015","unstructured":"Meric-Bernstam F, Brusco L, Shaw K et al (2015) Feasibility of large-scale genomic testing to facilitate enrollment onto genomically matched clinical trials. J Clin Oncol 33:2753\u20132762","journal-title":"J Clin Oncol"},{"key":"2628_CR9","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1080\/14737159.2017.1319280","volume":"17","author":"CM Statz","year":"2017","unstructured":"Statz CM, Patterson SE, Mockus SM (2017) Barriers preventing the adoption of comprehensive cancer genomic profiling in the clinic. Expert Rev Mol Diagn 17:549\u2013555","journal-title":"Expert Rev Mol Diagn"},{"key":"2628_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.neo.2022.100834","volume":"33","author":"A Ohmoto","year":"2022","unstructured":"Ohmoto A, Hayashi N, Fukada I et al (2022) Druggable gene alterations in Japanese patients with rare malignancy. Neoplasia 33:100834","journal-title":"Neoplasia"},{"key":"2628_CR11","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1634\/theoncologist.2017-0199","volume":"23","author":"S Kato","year":"2018","unstructured":"Kato S, Kurasaki K, Ikeda S et al (2018) Rare tumor clinic: the University of California San Diego Moores Cancer Center experience with a precision therapy approach. Oncologist 23:171\u2013178","journal-title":"Oncologist"},{"key":"2628_CR12","doi-asserted-by":"publisher","first-page":"1025367","DOI":"10.3389\/fonc.2023.1025367","volume":"13","author":"B Thapa","year":"2023","unstructured":"Thapa B, Ahmed G, Szabo A et al (2023) Comprehensive genomic profiling: does timing matter? Front Oncol 13:1025367","journal-title":"Front Oncol"},{"key":"2628_CR13","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1111\/cas.12525","volume":"105","author":"Y Ito","year":"2014","unstructured":"Ito Y, Miyashiro I, Ito H et al (2014) Long-term survival and conditional survival of cancer patients in Japan using population-based cancer registry data. Cancer Sci 105:1480\u20131486","journal-title":"Cancer Sci"},{"key":"2628_CR14","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1056\/NEJMoa1104390","volume":"365","author":"RA Burger","year":"2011","unstructured":"Burger RA, Brady MF, Bookman MA et al (2011) Incorporation of bevacizumab in the primary treatment of ovarian cancer. N Engl J Med 365:2473\u20132483","journal-title":"N Engl J Med"},{"key":"2628_CR15","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1056\/NEJMoa1911361","volume":"381","author":"I Ray-Coquard","year":"2019","unstructured":"Ray-Coquard I, Pautier P, Pignata S et al (2019) Olaparib plus bevacizumab as first-line maintenance in ovarian cancer. N Engl J Med 381:2416\u20132428","journal-title":"N Engl J Med"},{"key":"2628_CR16","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1001\/jamaoncol.2023.2283","volume":"9","author":"N Li","year":"2023","unstructured":"Li N, Zhu J, Yin R et al (2023) Treatment with niraparib maintenance therapy in patients with newly diagnosed advanced ovarian cancer: a phase 3 randomized clinical trial. JAMA Oncol 9:1230\u20131237","journal-title":"JAMA Oncol"},{"issue":"Suppl 2","key":"2628_CR17","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1002\/ijgo.12613","volume":"143","author":"N Mbatani","year":"2018","unstructured":"Mbatani N, Olawaiye AB, Prat J (2018) Uterine sarcomas. Int J Gynaecol Obstet 143(Suppl 2):51\u201358","journal-title":"Int J Gynaecol Obstet"},{"key":"2628_CR18","doi-asserted-by":"publisher","DOI":"10.1200\/PO.19.00227","author":"MA Hay","year":"2020","unstructured":"Hay MA, Severson EA, Miller VA et al (2020) Identifying opportunities and challenges for patients with sarcoma as a result of comprehensive genomic profiling of sarcoma specimens. JCO Precis Oncol. https:\/\/doi.org\/10.1200\/PO.19.00227","journal-title":"JCO Precis Oncol"},{"key":"2628_CR19","doi-asserted-by":"publisher","first-page":"2584","DOI":"10.1111\/jog.15767","volume":"49","author":"K Yoshino","year":"2023","unstructured":"Yoshino K, Kurita T, Takahashi F et al (2023) Annual report of the committee on gynecologic oncology, the Japan Society of Obstetrics and Gynecology: annual patient report for 2020 and annual treatment report for 2015. J Obstet Gynaecol Res 49:2584\u20132592","journal-title":"J Obstet Gynaecol Res"},{"key":"2628_CR20","doi-asserted-by":"publisher","first-page":"136","DOI":"10.3390\/cancers16010136","volume":"16","author":"Q Xi","year":"2023","unstructured":"Xi Q, Kage H, Ogawa M et al (2023) Genomic landscape of endometrial, ovarian, and cervical cancers in Japan from the database in the center for cancer genomics and advanced therapeutics. Cancers (Basel) 16:136","journal-title":"Cancers (Basel)"},{"key":"2628_CR21","doi-asserted-by":"publisher","first-page":"6170","DOI":"10.1002\/cam4.5349","volume":"12","author":"H Shirota","year":"2023","unstructured":"Shirota H, Komine K, Takahashi M et al (2023) Clinical decisions by the molecular tumor board on comprehensive genomic profiling tests in Japan: a retrospective observational study. Cancer Med 12:6170\u20136181","journal-title":"Cancer Med"},{"key":"2628_CR22","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1111\/cas.14674","volume":"112","author":"T Kondo","year":"2021","unstructured":"Kondo T, Matsubara J, Quy PN et al (2021) Comprehensive genomic profiling for patients with chemotherapy-naive advanced cancer. Cancer Sci 112:296\u2013304","journal-title":"Cancer Sci"},{"key":"2628_CR23","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1093\/jjco\/hyaa277","volume":"51","author":"J Kikuchi","year":"2021","unstructured":"Kikuchi J, Ohhara Y, Takada K et al (2021) Clinical significance of comprehensive genomic profiling tests covered by public insurance in patients with advanced solid cancers in Hokkaido, Japan. Jpn J Clin Oncol 51:753\u2013761","journal-title":"Jpn J Clin Oncol"},{"key":"2628_CR24","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.3390\/diagnostics12081903","volume":"12","author":"I Prieto-Potin","year":"2022","unstructured":"Prieto-Potin I, Idrovo F, Suarez-Gauthier A et al (2022) Comprehensive approach to genomic and immune profiling: insights of a real-world experience in gynecological tumors. Diagnostics (Basel) 12:1903","journal-title":"Diagnostics (Basel)"},{"key":"2628_CR25","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1007\/s10147-024-02533-z","volume":"29","author":"N Hayashi","year":"2024","unstructured":"Hayashi N, Mori S, Ohmoto A et al (2024) Availability of genome-matched therapy based on clinical practice. Int J Clin Oncol 29:964\u2013971","journal-title":"Int J Clin Oncol"},{"key":"2628_CR26","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.3390\/cancers14051352","volume":"14","author":"VK Maruthi","year":"2022","unstructured":"Maruthi VK, Khazaeli M, Jeyachandran D et al (2022) The clinical utility and impact of next generation sequencing in gynecologic cancers. Cancers (Basel) 14:1352","journal-title":"Cancers (Basel)"},{"key":"2628_CR27","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1002\/cam4.2064","volume":"8","author":"M Huang","year":"2019","unstructured":"Huang M, Hunter T, Slomovitz B et al (2019) Impact of molecular testing in clinical practice in gynecologic cancers. Cancer Med 8:2013\u20132019","journal-title":"Cancer Med"}],"container-title":["International Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-024-02628-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10147-024-02628-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-024-02628-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T07:58:12Z","timestamp":1732607892000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10147-024-02628-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,25]]},"references-count":27,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["2628"],"URL":"https:\/\/doi.org\/10.1007\/s10147-024-02628-7","relation":{},"ISSN":["1341-9625","1437-7772"],"issn-type":[{"value":"1341-9625","type":"print"},{"value":"1437-7772","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,25]]},"assertion":[{"value":"3 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}